Aloxiprin
Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.[1] It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug.[1] It is a chemical compound of aluminium hydroxide and aspirin.[2][3]
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.041.481  |
| Chemical and physical data | |
| Formula | C18H15AlO9 |
| Molar mass | 402.288 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Alternative names and combinations
- Palaprin Forte.[4]
- Askit Powders - A powder combination of aspirin, aloxiprin and caffeine.[5]
Contraindications
- People with allergies to salicylates.
- People with gastrointestinal ulcers.
- People with liver or kidney damage.
- Pregnant women in the 3rd trimester.
- Women who are breastfeeding.
- Use with other salicylates.
- Use with NSAIDs.
References
- MIMS. "Aloxiprin". MIMS. Retrieved 16 April 2011.
- Encarta. "Aloxiprin". Encarta. Retrieved 16 April 2011.
- CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. doi:10.1111/j.2042-7158.1963.tb12743.x. PMID 14024235. S2CID 33366977.
- Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British Journal of Clinical Practice. 22 (9): 392–4. PMID 4876729.
- Net Doctor UK. "Askit Powders". Treatments for joint, muscle and bone conditions. Retrieved 16 April 2011.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.